Skip to content

Envoy Medical COCH Q2 2025 earnings

Reported July 31, 2025 · Before market open

Revenue$78.0KBeat by $11.8K
EPS-$0.32Miss by $0.03
Revenue estimate$66.3K
EPS estimate-$0.29

Next report

Jul 30, 2026 (Tomorrow)
Revenue estimate$100.0K
EPS estimate-$0.09

Financials

Q2 2025

Income statement

See full
Revenue$78.0K+14.7%
Gross profit-$156.0K+11.9%
Operating income-$5.1M-4.5%
Net income-$5.7M-44.2%
EPS (diluted)-$0.32-10.3%

Balance sheet

See full
Cash & equivalents$5.3M+204%
Total equity-$29.9M-141%
Total assets$9.9M+46.9%

Cash flow

See full
Operating cash flow-$4.5M+4.0%
CapEx$1.0K-99.6%
Free cash flow-$4.5M+8.8%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$30.28M-34.5%
P/S136.4×-16.8×

Profitability

See full
Gross margin-262.2%+290pp
Operating margin-8,873%+4,785pp
Net margin-9,579.3%-80,447pp
FCF margin-7,445.5%+258pp

Returns & leverage

See full
Current ratio0.9×+0.3×

Versus estimates

Ask the moment Envoy Medical reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Envoy Medical report Q2 2025 earnings?
Envoy Medical (COCH) reported Q2 2025 earnings on July 31, 2025 before market open.
What were Envoy Medical's Q2 2025 revenue and EPS?
Envoy Medical reported revenue of $78.0K and eps of $-0.32 for Q2 2025.
Did Envoy Medical beat estimates in Q2 2025?
Revenue beat the consensus estimate of $66.3K by $11.8K. EPS missed the consensus estimate of $-0.29 by $0.03.
How did Envoy Medical's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 14.7% from $68.0K a year earlier and eps declined 18.5% from $-0.27.
Where can I find Envoy Medical's Q2 2025 SEC filings?
You can read the 10-Q periodic report (0001213900-25-069663) directly on SEC EDGAR. The filing index links above go to sec.gov.